Regeneron Pharmaceuticals Inc (MEX:REGN)
MXN 18667 16.7 (0.09%) Market Cap: 2.04 Tn Enterprise Value: 1.90 Tn PE Ratio: 24.59 PB Ratio: 3.63 GF Score: 92/100

Regeneron Pharmaceuticals Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript

May 30, 2023 / 04:30PM GMT
Release Date Price: MXN13136.11
Tyler Martin Van Buren
TD Cowen, Research Division - MD & Senior Equity Research Analyst

All right. We'll give it a couple of seconds for everyone to join. Okay. So with that, welcome, everyone, again, to the TD Cowen's Fourth Annual Oncology Innovation Summit: Highlights for ASCO and EHA. My name is Tyler Van Buren, senior biotech analyst here at TD Cowen. For our next session, we're very pleased to have a fireside chat with Regeneron. And it's my sincere pleasure to introduce Izzy Lowy, Senior Vice President of Solid Organ Oncology Development; and Andreas Sirulnik, Senior Vice President of Heme-Onc Development. Izzy and Andreas, it's a privilege to have you both here. Thank you very much for joining me.

L. Andres Sirulnik
Regeneron Pharmaceuticals, Inc. - SVP of Translational & Clinical Sciences, Hematology

Thank you for having us, Tyler.

Tyler Martin Van Buren
TD Cowen, Research Division - MD & Senior Equity Research Analyst

Ryan, Head of IR -- Ryan Crowe, Head of IR, thank you very much for being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot